Tradestie Institutional Equity Comparison Engine

SER vs PLYX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SER Overall Edge

SER Captures Institutional Edge (2โ€“0 Pillars ยท 6โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Serina Therapeutics, Inc. (SER) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, SER trades at N/M Forward P/E with 0.0% operating margin (+154.9% YoY revenue) versus PLYX at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, SER sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against PLYX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
SER N/M vs PLYX N/M Fwd P/E
Growth & Margin Winner SER
Op Margin 0.0% vs N/A ยท YoY +154.9% vs N/A
Momentum & Technical Winner SER
1Y -68.1% vs -95.7% ยท 52W Pos 2% vs 0%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
SER NYSE American
Serina Therapeutics, Inc.
Pharmaceutical Preparations
$1.20
-11.11% 1D
Market Cap $35.9M
1M Return -32.2%
1Y Return -68.09%
Forward P/E N/M
Unified AI Score
43.1 / 100 HOLD
Tech 25.0 Fund 57.0 Flow 50.0 Mom 59.0
PLYX US Equity
PLYX
Institutional Equity
$1.51
-6.21% 1D
Market Cap N/A
1M Return -22.16%
1Y Return -95.69%
Forward P/E N/M
Unified AI Score
43.3 / 100 HOLD
Tech 33.0 Fund 52.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SER -68.09% PLYX -95.69% Spread: +39.81 pp (SER Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
SER TTM Op. Margin: 0.0% PLYX TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SER vs PLYX. Trailing 12-month operating profitability (SER 0.0% vs PLYX N/A) and valuation multiples (SER N/M vs PLYX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SER (6) vs PLYX (1)
Institutional Metric SER PLYX Criterion Row Winner
Market Capitalization Scale $35.9M N/A Larger Scale SER
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +154.9% N/A Higher Growth SER
Operating Margin (TTM) Profitability 0.0% N/A Higher Margin SER
Net Profit Margin Profitability 0.0% N/A Higher Margin SER
Return on Equity (ROE) Capital Efficiency -207.9% N/A Higher ROE SER
52-Week Range Position Momentum 2% ($1โ€“$4) 0% ($2โ€“$49) Stronger Trend SER
Beta / 30D Volatility Risk Regime 1.40ฮฒ ยท 98% Vol 1.43ฮฒ ยท 60% Vol Lower Realized Risk PLYX
Unified Institutional Score Composite Signal 43.1 / 100 (HOLD) 43.3 / 100 (HOLD) Higher Composite Tie

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SER vs PLYX Buy Guide
SER UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live SER Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PLYX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PLYX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SER nor PLYX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.